<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Vet Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">J. Vet. Med. Sci</journal-id><journal-id journal-id-type="publisher-id">JVMS</journal-id><journal-title-group><journal-title>The Journal of Veterinary Medical Science</journal-title></journal-title-group><issn pub-type="ppub">0916-7250</issn><issn pub-type="epub">1347-7439</issn><publisher><publisher-name>The Japanese Society of Veterinary Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4829508</article-id><article-id pub-id-type="pmid">26596634</article-id><article-id pub-id-type="publisher-id">15-0255</article-id><article-id pub-id-type="doi">10.1292/jvms.15-0255</article-id><article-categories><subj-group subj-group-type="heading"><subject>Internal Medicine</subject><subj-group><subject>Full Paper</subject></subj-group></subj-group></article-categories><title-group><article-title>Analyses of a satiety factor NUCB2/nesfatin-1; gene expressions andmodulation by different dietary components in dogs</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>NOZAWA</surname><given-names>Satoshi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>KIMURA</surname><given-names>Tomoko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>KURISHIMA</surname><given-names>Miyuki</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>MIMURA</surname><given-names>Kana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>SAEKI</surname><given-names>Kaori</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>MIKI</surname><given-names>Yohei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>ODA</surname><given-names>Hitomi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>MORI</surname><given-names>Akihiro</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>MOMOTA</surname><given-names>Yutaka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>AZAKAMI</surname><given-names>Daigo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>ISHIOKA</surname><given-names>Katsumi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref rid="cor1" ref-type="corresp"><sup>*</sup></xref></contrib><aff id="aff1"><label>1)</label>Department of Veterinary Nursing, School of Veterinary
Nursing and Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science
University, 1&#x02013;7&#x02013;1 Kyonan-cho, Musashino-shi, Tokyo 180&#x02013;8602, Japan</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Correspondence to: Ishioka, K., Department of Veterinary
Nursing, School of Veterinary Nursing and Technology, Faculty of Veterinary Science,
Nippon Veterinary and Life Science University, 1&#x02013;7&#x02013;1 Kyonan-cho, Musashino-shi, Tokyo
180&#x02013;8602, Japan. e-mail: <email xlink:href="katsumi@nvlu.ac.jp">katsumi@nvlu.ac.jp</email></corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>11</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2016</year></pub-date><volume>78</volume><issue>3</issue><fpage>411</fpage><lpage>417</lpage><history><date date-type="received"><day>28</day><month>4</month><year>2015</year></date><date date-type="accepted"><day>10</day><month>11</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9;2016 The Japanese Society of Veterinary Science</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><p>Nesfatin-1 is an anorexic peptide derived from a precursor, nucleobindin-2 (NUCB2), which
is distributed in various organs, coexists with ghrelin in the gastric X/A-like cells and
closely relates to an appetite control in rodents and humans. Nesfatin-1 may be a
significant factor addressing the satiety also in veterinary medicine, however, there are
few reports about nesfatin-1 in dogs. In the present study, we detected canine
NUCB2/nesfatin-1 mRNA in various tissues, especially abundant in pancreas,
gastrointestinal tracts, testis and cerebellum. We examined circulating nesfatin-1
concentrations and NUCB2/nesfatin-1 mRNA expressions in upper gastrointestinal tracts
(gastric corpus, pyloric antrum and duodenum) in dogs fed on different types of diets.
Plasma nesfatin-1 concentrations in the dogs were approximately 4
<italic>n</italic>g/m<italic>l</italic> and they did not change after feeding through
the study, however, NUCB2/nesfatin-1 mRNA expressions in pyloric antrum were 1.84-fold
higher in the dogs fed on a High fiber/High protein diet (<italic>P</italic>&#x0003c;0.001),
1.48-fold higher in the dogs fed on a High fat/Low protein diet
(<italic>P</italic>&#x0003c;0.05) and 1.02-fold higher in the dogs fed on a Low fat/High
carbohydrate diet (not significant) comparing to those on a control diet. It was concluded
that High fiber/High protein and High fat/Low protein diets increased NUCB2/nesfatin-1
production in canine gastrointestinal tracts. These results may set the stage for further
investigations of canine NUCB2/nesfatin-1, which may relate to satiety effects in
dogs.</p></abstract><kwd-group><kwd>anorexic peptide</kwd><kwd>canine</kwd><kwd>nesfatin-1</kwd><kwd>nucleobindin-2</kwd><kwd>obesity</kwd></kwd-group></article-meta></front><body><p>Obesity is defined as excessive body fat accumulation, and the prevalence of obesity in dogs
has increased in recent years [<xref rid="r3" ref-type="bibr">3</xref>]. Obese dogs have
higher risks in hyperlipidemia, pancreatitis, arthritic disorders and shortened life-span, so
it is considered to be a condition which must be treated [<xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r14" ref-type="bibr">14</xref>]. Obesity is basically caused by
overfeeding and/or less exercise, so the dietary restriction is a key technique for a weight
control. However, simply reduced energy feeding causes begging behaviors to animals, and the
development of reducing diets with enough satiety effects is an important challenge. However,
it is difficult to assess the feeling of satiety in animals, because it is a subjective sense
which can not be determined by routine techniques. Recently, it has been revealed that many
peptides are involved in the eating behavior in rodents, humans and dogs. For example, leptin
is a representative adipokine that is produced by adipocytes and suppresses appetite. In
contrast, ghrelin is a peptide produced in the stomach and increases appetite. We have
investigated the functions and clinical usefulness of these peptides in cats and dogs, and
discovered that leptin is available as an obese marker in dogs and ghrelin functions as a
feeding stimulant in cats and dogs [<xref rid="r12" ref-type="bibr">12</xref>].</p><p>Nesfatin-1 is an 82-amino acid peptide derived from the precursor, NEFA/nucleobindin-2
(NUCB2), in humans and rodents [<xref rid="r19" ref-type="bibr">19</xref>]. Centrally,
PVN-NTS-Melanocortin (MC) 3/4 receptors function as the appetite control center [<xref rid="r7" ref-type="bibr">7</xref>, <xref rid="r15" ref-type="bibr">15</xref>, <xref rid="r18" ref-type="bibr">18</xref>, <xref rid="r34" ref-type="bibr">34</xref>]. Nesfatin-1
stimulates afferent vagal nerve cells locally and increases the pro-opiomelanocortin (POMC)
mRNA expression in NTS through the afferent nerve system. Alpha-melanocyte-stimulating hormone
which forms by processing of POMC inhibits appetite via MC 3/4 receptors [<xref rid="r17" ref-type="bibr">17</xref>, <xref rid="r26" ref-type="bibr">26</xref>]. Nesfatin-1
has been detected in appetite-control hypothalamic nuclei and in many peripheral tissues, such
as stomach, adipose tissue, pancreas, pituitary gland and testis of the rat and goldfish
[<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r27" ref-type="bibr">27</xref>, <xref rid="r29" ref-type="bibr">29</xref>, <xref rid="r35" ref-type="bibr">35</xref>]. In particular, Stengel <italic>et al.</italic> [<xref rid="r27" ref-type="bibr">27</xref>] have reported that NUCB2 mRNA expression in gastric
mucosa was 10 times of that in brain in rats. Additionally, nesfatin-1 suppresses food
consumption when it was administered to rats centrally or peripherally [<xref rid="r18" ref-type="bibr">18</xref>, <xref rid="r26" ref-type="bibr">26</xref>]. It has been hypothesized
that peripheral nesfatin-1 acts via the blood-brain barrier [<xref rid="r20" ref-type="bibr">20</xref>, <xref rid="r23" ref-type="bibr">23</xref>] or the afferent vagal nerves [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r25" ref-type="bibr">25</xref>, <xref rid="r36" ref-type="bibr">36</xref>], however, the detail pathways underlying its action are
unknown at present.</p><p>NUCB2/nesfatin-1 is located in the gastric X/A-like cells coexisting with ghrelin [<xref rid="r27" ref-type="bibr">27</xref>], and the NUCB2 mRNA and nesfatin-1 protein are affected
by fasting/refeeding cycles in rodent [<xref rid="r24" ref-type="bibr">24</xref>]. Moreover,
Gonkowski <italic>et al.</italic> [<xref rid="r10" ref-type="bibr">10</xref>] have detected
nesfatin-1 -like immunoreactive cells in the mucosal layer of the canine digestive tracts, and
Watanabe <italic>et al.</italic> [<xref rid="r31" ref-type="bibr">31</xref>] have reported
that nesfatin-1 inhibited gastric contractions in the fasted state when administrated to dogs.
In this way, the relationship between nesfatin-1 and gastrointestinal tracts is focused also
in veterinary science. However, there are few reports about nesfatin-1 in dogs.</p><p>In the present study, we demonstrated following experiments for the purpose of better
understanding of canine NUCB2/nesfatin-1, i.e. 1) we cloned cDNA of canine NUCB2/nesfatin-1
and revealed the tissue distribution, especially in the upper gastrointestinal tracts, 2) we
investigated the change of plasma nesfatin-1 concentrations before and after feeding of
different types of diets, and 3) we investigated the change of mRNA expressions of
NUCB2/nesfatin-1 in the stomach and duodenum of the dogs fed on different types of diets
chronically, which may relate to possible satiety effects. Focus is on the gene expression of
nesfatin-1 in the gastrointestinal system, because they are directly contacting organs to
dietary components.</p><sec sec-type="materials|methods" id="s1"><title>MATERIALS AND METHODS</title><p><italic>Sample preparation</italic>: Canine tissue samples collected and kept frozen for
other research were used for RNA extraction in this study. Total RNAs of the 14 canine
tissues (cerebrum, cerebellum, esophagus, stomach, pancreas, small intestine, liver, heart,
spleen, kidney, bladder, skeletal muscle, testis and adipose tissue) were extracted by
homogenizing each sample (50&#x02013;150 mg) in TRI Reagent (Sigma, St. Louis, MO, U.S.A.). For more
detailed analysis of NUCB2/nesfatin-1 expressions in canine upper-gastrointestinal tracts, 4
kinds of tissues (gastric fundus, gastric corpus, pyloric antrum and duodenum) were sampled
using an endoscope from a healthy dog which were used in the following study. Total RNA was
extracted using RNeasy Plus Mini Kit (QIAGEN, Tokyo, Japan).</p><p><italic>Cloning and sequencing of canine NUCB2/nesfatin-1</italic>: Genome sequence
information of canine NUCB2/nesfatin-1 was obtained from the GenBank (accession, XM534078).
The designed primer sequences for cloning and sequencing of canine NUCB2/nesfatin-1 were as
follows: NUCB2/nesfatin-1 Forward, 5&#x02032;- atgaggtggaggatcatctt-3&#x02032;; Reverse, 5&#x02032;-
aagagcatggtggtctatgc-3&#x02032;. Total RNA extracted from a stomach sample was reverse-transcribed
into cDNA using TaKaRa RNA PCR Kit (AMV) Ver.3.0 (TaKaRa, Otsu, Japan) at the following
conditions, 42&#x000b0;C for 30 min and 99&#x000b0;C for 5 min. PCR amplification was performed using 50
<italic>&#x000b5;l</italic> reactions containing 5 <italic>&#x000b5;l</italic> of 10X PCR buffer, 4
<italic>&#x000b5;l</italic> of dNTPs, 2 <italic>&#x000b5;l</italic> of magnesium chloride, 1
<italic>&#x000b5;l</italic> of each primer, 0.25 <italic>&#x000b5;l</italic> of LA Taq DNA polymerase
(TaKaRa), 2 <italic>&#x000b5;l</italic> of template cDNA and 34.75 <italic>&#x000b5;l</italic> of distilled
water. The PCR protocol consisted of an initial denaturing cycle at 96&#x000b0;C for 2 min followed
by a 35 cycle amplification step (96&#x000b0;C for 30 sec, 60&#x000b0;C for 30 sec and 72&#x000b0;C for 30 sec) with
a final extension cycle at 72&#x000b0;C for 2 min. The PCR products were electrophoresed in 2%
agarose gel to confirm the expected size and subcloned into pT-7 blue vectors (Novagen,
Madison, WI, U.S.A.) using the Ligation Mix (DNA Ligation Kit; TaKaRa). The ligated plasmid
was transformed into NovaBlue <italic>E. coli</italic> cells (Novagen) and sequenced using
an automated ABI Prism 310 Genetic Analyzer (Applied Biosystems, Foster City, CA,
U.S.A.).</p><p><italic>Quantitative real-time PCR analysis of canine NUCB2/nesfatin-1 mRNA</italic>: For
the quantitative analyses, total RNA samples of the 14 tissues and 4 upper gastrointestinal
tracts were reverse-transcribed into cDNA using a QuantiTect Rev. Transcription Kit
(QIAGEN). We demonstrated quantitative real-time PCR (qRT-PCR) to compare mRNA expression
levels among the canine tissues. The primer sequences were as follows, NUCB2/nesfatin-1
Forward, 5&#x02032;- caagtgattgatgtgctggaa-3&#x02032;; Reverse, 5&#x02032;- gccacttgttgtcttttcagttc-3&#x02032;; beta-actin
Forward, 5&#x02032;-gccaaccgtgagaagatgact-3&#x02032;; and Reverse, 5&#x02032;- cccagagtccatgacaataccag-3&#x02032;. The
qRT-PCR reactions were carried out in triplicate with a commercial kit (Perfect Real Time
SYBR Premix Ex Taq II) using an Applied Biosystems 7300 Real Time PCR Sequence Detection
System (Applied Biosystems). The protocol was as follows, 94&#x000b0;C for 10 sec, followed by 40
cycles of 95&#x000b0;C for 5 sec and 60&#x000b0;C for 34 sec. Following amplification, a melting curve
analysis program was performed to verify the authenticity of the amplified products by their
specific melting temperatures (Applied Biosystems). The resulting products were subjected to
nucleotide sequencing to confirm their specificity. PCR amplification was carried out in 20
<italic>&#x000b5;l</italic> solutions containing 1 <italic>&#x000b5;l</italic> of template cDNA, 0.8
<italic>&#x000b5;l</italic> of each specific primer (10 <italic>&#x000b5;</italic>M), 10
<italic>&#x000b5;l</italic> of SYBR Premix Ex Taq, 0.4 <italic>&#x000b5;l</italic> of ROX reference dye II
and 7.0 <italic>&#x000b5;l</italic> of distilled water. After qRT-PCR amplification, absolute
quantification was performed according to the method of Whelan <italic>et al.</italic>
[<xref rid="r32" ref-type="bibr">32</xref>], by establishing a linear amplification curve
from 10-fold serial dilutions of cloned and sequenced plasmid DNA containing target PCR
products. The expression level of the beta-actin gene as a housekeeping gene was quantified
by the same method, and the expression levels of the target genes were rectified by the
expression levels of the beta-actin gene.</p><p><italic>Feeding and sampling protocol</italic>: Four adult beagle dogs (1 castrated male
and 3 spayed females, 6.5&#x02013;11.8 kg body weights and 4&#x02013;7 years old) were maintained in the
laboratory for research purposes and served as healthy controls. All dogs were fed on a
commercial diet (Select Skin Care as maintenance diet, Royal Canin Japon, Tokyo, Japan)
twice a day (8 am and 8 pm), and the energy intake was set at 1/2 &#x000d7; 1.6 &#x000d7; RER
(BW<sup>0.75</sup> &#x000d7; 70) for each feeding period (RER, resting energy requirement; BW,
body weight) for the dogs [<xref rid="r4" ref-type="bibr">4</xref>]. In order to investigate
short-term effects of different nutrient composition on nesfatin-1 gene expressions of upper
gastrointestinal tracts, the 4 healthy dogs were fed on the same diet for 7 days followed by
diet rotations (<xref ref-type="fig" rid="fig_001">Fig. 1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>Feeding rotations of the dogs. The dogs underwent diet regimen rotations, with each
regimen for 7 days. The orders of the diets are shown in <xref ref-type="supplementary-material" rid="pdf_001">Supplementary Table 1</xref>. Blood
was always collected on the seventh day of each diet regimen. Upper gastrointestinal
tract samples were collected on the last day of each diet regimen by endoscopy from
the anesthetized dogs.</p></caption><graphic xlink:href="jvms-78-411-g001"/></fig> and See Appendix: <xref ref-type="supplementary-material" rid="pdf_001">Supplementary Table 1</xref>). The prescription diets used for the
rotations were as follows, Select Skin Care dry diet as Control diet, Weight Control dry
diet as High fiber/High protein diet, Renal dry diet as High fat/Low protein diet and Gastro
Intestinal Low Fat dry diet as Low fat/High carbohydrate diet (Royal Canin Japon, See
Appendix: <xref ref-type="supplementary-material" rid="pdf_001">Supplementary Table 2</xref>).</p><p>Three dogs (dogs 1, 3 and 4, See Appendix: <xref ref-type="supplementary-material" rid="pdf_001">Supplementary Table 2</xref>) were used for the
circulating nesfatin-1 assay. On the seventh day of feeding, blood samples were collected
from the dogs prior and 30, 60, 120 and 180 min postprandial of the diets. They were
collected into chilled tubes containing EDTA-2Na and 500 KIU aprotinin (Merck Millipore,
Darmstadt, Germany), and centrifuged at 1,000 g for 10 min at 4&#x000b0;C to obtain plasma. Plasma
samples were used to determine nesfatin-1 concentration, which was measured using a
commercial Human Nesfatin-1 EIA Competition ELISA Kit (LifeSpan BioSciences, Inc., Seattle,
WA, U.S.A.) according to the manufacturer&#x02019;s protocol (the inter-assay CV and intra-assay CV
were &#x0003c;12% and &#x0003c;10%, respectively).</p><p>Four dogs (dogs 1, 2, 3 and 4, See Appendix: <xref ref-type="supplementary-material" rid="pdf_001">Supplementary Table 2</xref>) were used for the
NUCB2/nesfatin-1 mRNA expression assay. On the last day of each interval period, the dogs
underwent overnight fasting. The dogs were sedated by intravenous administration of 0.25
mg/kg droperidol (Droleptan; Daiichi Sankyo Co., Ltd., Tokyo, Japan) and anesthetized by
intravenous administration of 7 mg/kg propofol (Rapinovet; Intervet/Schering-Plough Animal
Health Corp., Ltd., Tokyo, Japan). Anesthesia was maintained by inhalation of isoflurance
(Escain; Merck Ltd., Tokyo, Japan) and oxygen. Stomach and small intestine samples were
collected every week midmorning using an endoscope from each anesthetized animal under
minimal stress conditions according to guidelines of the Nippon Veterinary and Life Science
University. The tissue samples were immediately transferred into RNAlater solution (Sigma)
and stores at &#x02212;80&#x000b0;C until measurement of NUCB2/nesfatin-1 mRNA expression by qRT-PCR.
Approval for the work was given by the Nippon Veterinary and Life Science University Animal
Research Committee.</p><p><italic>Statistical analyses</italic>: Data are presented as the mean &#x000b1; SEM. Statistical
analyses were demonstrated using two-way repeated measures ANOVA for comparison of plasma
nesfatin-1 and one-way repeated measures ANOVA and Bonferroni&#x02019;s multiple comparison test for
comparison of nesfatin-1 mRNA expressions, using GraphPad Prism 5 (GraphPad Software, Inc.,
La Jolla, CA, U.S.A.).</p></sec><sec sec-type="results" id="s2"><title>RESULTS</title><p><italic>cDNA cloning of canine NUCB2/nesfatin-1</italic>: Open reading frame of the canine
nesfatin-1 consisted of 243 nucleotides, which encodes 81 amino acid protein sequence
(registered as accession AB622125). The deduced canine NUCB2/nesfatin-1 protein sequence
displayed a high identity to bovine (97%), human (92%), murine (86%) and rat (84%)
NUCB2/nesfatin-1 sequences. Additionally, bovine, human and rodent nesfatin-1 proteins
consist of 82 amino acids, although canine nesfatin-1 consists of 81 amino acids. Alignment
analysis revealed that the 12th amino acid had been lost from the N-terminus in the dog (See
Appendix: <xref ref-type="supplementary-material" rid="pdf_002">Supplementary Fig. 1</xref>).</p><p><italic>Tissue distribution of NUCB2/nesfatin-1 mRNA</italic>: NUCB2/nesfatin-1 was
expressed in 10 of 14 tissues tested in the dog, and the order of the highest to the lowest
was as follows, pancreas&#x0003e;bladder&#x0003e;stomach&#x0003e;cerebellum&#x0003e;esophagus&#x0003e;small
intestine&#x0003e;spleen&#x0003e;testis&#x0003e;kidney&#x0003e;cerebrum (<xref ref-type="fig" rid="fig_002">Fig.
2a</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p>Values are expressed as copies per 1 <italic>n</italic>g of cDNA. (a)
NUCB2/nesfatin-1 mRNA expression levels in various canine tissues as determined by
qRT-PCR. (b) NUCB2/nesfatin-1 mRNA expression levels in endoscopically-obtained
stomach (gastric corpus, gastric fundus and pyloric antrum) and duodenum samples as
determined by qRT-PCR.</p></caption><graphic xlink:href="jvms-78-411-g002"/></fig>). The NUCB2/nesfatin-1 mRNA expressions of cerebellum, stomach, pancreas and bladder
were higher (&#x0003e;400 copies/<italic>n</italic>g cDNA), and those of cerebrum, esophagus,
small intestine, spleen, kidney and testis were middle (100&#x02013;400 copies/<italic>n</italic>g
cDNA). On the other hand, liver, heart, skeletal muscle and adipose tissue had poor
NUCB2/nesfatin-1 mRNA expressions (&#x0003c;100 copies/<italic>n</italic>g cDNA). In
NUCB2/nesfatin-1 expression of upper gastrointestinal tracts, the order of the highest to
the lowest was as follows, pyloric antrum&#x0003e;gastric fundus&#x0003e;gastric corpus&#x0003e;duodenum
(<xref ref-type="fig" rid="fig_002">Fig. 2b</xref>). Most rich NUCB2/nesfatin-1 mRNA
expression in pyloric antrum was 567 copies/<italic>n</italic>g cDNA.</p><p><italic>Influence of the different dietary components on canine plasma nesfatin-1</italic>:
The results of the plasma nesfatin-1 assay of the 3 healthy dogs fed on different types of
diets are shown in <xref ref-type="fig" rid="fig_003">Fig. 3</xref><fig orientation="portrait" fig-type="figure" id="fig_003" position="float"><label>Fig. 3.</label><caption><p>Mean temporal changes in postprandial plasma nesfatin-1 concentrations under
different types of diets in healthy dogs. Values are expressed as means &#x000b1; SEM
(n=3).</p></caption><graphic xlink:href="jvms-78-411-g003"/></fig>. Basal plasma nesfatin-1 concentrations did not change after 1-week feeding of
different types of diets statistically, however, those after High fiber/High protein and
High fat/Low protein diets tended to be higher than others. Plasma nesfatin-1 concentrations
did not show significant changes from prior to 180 min after the dogs were fed.</p><p><italic>Influence of the different dietary components on canine NUCB2/nesfatin-1</italic>:
The results of the NUCB2/nesfatin-1 mRNA expressions of upper gastrointestinal tracts
(gastric corpus, pyloric antrum and duodenum) examined in the 4 healthy dogs fed on
different types of diets are shown in <xref ref-type="fig" rid="fig_004">Fig. 4</xref><fig orientation="portrait" fig-type="figure" id="fig_004" position="float"><label>Fig. 4.</label><caption><p>NUCB2/nesfatin-1 mRNA expressions in upper gastrointestinal tracts of the dogs fed on
different types of diets are indicated. The values were normalized by the expression
levels of beta-actin gene. Each value of mRNA expression was denoted as the relative
value to the control diet and expressed as mean &#x000b1; SEM (n=4). Different alphabetic
letters indicate statistically different, a vs. b, <italic>P</italic>&#x0003c;0.001; a vs.
b&#x02019;, <italic>P</italic>&#x0003c;0.05, Bonferroni&#x02019;s Multiple Comparison Test.</p></caption><graphic xlink:href="jvms-78-411-g004"/></fig>. In gastric corpus, nesfatin-1 mRNA expression was 1.46-fold higher in the dogs fed
on a High fiber/High protein diet, 1.10-fold higher in the dogs fed on a High fat/Low
protein diet and 0.83-fold higher in the dogs fed on a Low fat/High carbohydrate diet diets
comparing to those on a control diet, but the differences were not statistically
significant. In pyloric antrum, the nesfatin-1 mRNA expression was 1.84-fold higher in the
dogs fed on a High fiber/High protein diet (<italic>P</italic>&#x0003c;0.001), 1.48-fold higher
in the dogs fed on a High fat/Low protein diet (<italic>P</italic>&#x0003c;0.05) and 1.02-fold
higher in the dogs fed on a Low fat/High carbohydrate diet (not significant) comparing to
those on a control diet. Moreover, the difference in High fiber/High protein diet and High
fat/Low protein diet was statistically significant comparing to those on a Low fat/High
carbohydrate diet, too (<italic>P</italic>&#x0003c;0.001 and <italic>P</italic>&#x0003c;0.05,
respectively). In duodenum, nesfatin-1 mRNA expression was 1.09-fold higher in the dogs fed
on a High fiber/High protein diet, 1.17-fold higher in the dogs fed on a High fat/Low
protein diet and 0.83-fold higher in the dogs fed on a Low fat/High carbohydrate diet
comparing to those on a control diet, but the differences were not statistically
significant.</p></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>The cloned cDNA of canine NUCB2/nesfatin-1 was highly homologous to those of other species
[<xref rid="r19" ref-type="bibr">19</xref>]. In the current study, we revealed that canine
NUCB2/nesfatin-1 mRNA is abundant in pancreas, gastrointestinal tracts, testis and
cerebellum. In a previous paper, it has been reported that NUCB2/nesfatin-1 was much
expressed in the cerebellum, stomach (especially pyloric antrum) and pancreas in rodents
[<xref rid="r35" ref-type="bibr">35</xref>]. Moreover, Garc&#x000ed;a <italic>et al.</italic>
[<xref rid="r9" ref-type="bibr">9</xref>] have reported the expression of NUCB2/nesfatin-1
in Leydig cells of testis, which is under the control of developmental, nutritional and
gonadotropic cues. The current results are basically identical to these reports in other
species. However, these studies aimed at NUCB2/nesfatin-1 in limited types of tissues, and
analyses in whole body have not ever been performed. Therefore, there are no data about
other organs that we compared. In particular, we detected the highest expressions of
NUCB2/nesfatin-1 in bladder, spleen and kidney, although their physiological implications
are not clear.</p><p>In the present study, we measured plasma nesfatin-1 concentrations and quantified the
NUCB2/nesfatin-1 mRNA expressions in the gastrointestinal tracts when the dogs were fed on
different types of nutrient for 7 days. Plasma concentrations of nesfatin-1 in the dogs were
approximately 4 <italic>n</italic>g/m<italic>l</italic>, and they did not change after
feeding, harmonizing the results by Watanabe <italic>et al.</italic> [<xref rid="r31" ref-type="bibr">31</xref>]. In addition, Tsuchiya <italic>et al.</italic> [<xref rid="r30" ref-type="bibr">30</xref>] have reported that nesfatin-1 concentrations did not change
significantly in humans by meal tests during 0&#x02013;240 min. These results do not harmonize the
hypothesis that circulating nesfatin-1 increases postprandially and acts on brains through
the blood-brain barrier to cause satiety effects.</p><p>On the other hand, we detected the significant change of NUCB2/nesfatin-1 mRNA expressions,
i.e. High fiber/High protein diet and High fat/Low protein diet increased NUCB2/nesfatin-1
mRNA expressions in pyloric antrum significantly. Those in other regions of gastrointestinal
tracts (gastric corpus and duodenum) did not show significant change, but tended to be
similar to that in pyloric antrum. It is possible that locally produced nesfatin-1
stimulates vagal nerves to cause the satiety effects by acting on brain through the afferent
nerve system. However, it is no more than a hypothesis at this moment, and further studies
are necessary to prove it. Ramanjaneya <italic>et al.</italic> [<xref rid="r24" ref-type="bibr">24</xref>] have reported that the mice fed on a high fat diet for 12 or 20 weeks
showed increased nesfatin-1 production in adipose tissues. In the present study, we revealed
that NUCB2/nesfatin-1 mRNA expressions are increased in gastrointestinal tracts after
feeding of High fat (/Low protein) diet. This may support the
relationship between high fat diet and NUCB2/nesfation-1 production in dogs. A number of
studies have showed that fiber-rich foods can increase the sense of satiety and decrease
short-term food intake in humans [<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r16" ref-type="bibr">16</xref>, <xref rid="r22" ref-type="bibr">22</xref>, <xref rid="r33" ref-type="bibr">33</xref>], and it is also reported that fiber causes a satiety
effect by gastric distension in companion animals [<xref rid="r21" ref-type="bibr">21</xref>]. In the present study, we detected the highest NUCB2/nesfatin-1 mRNA expressions
in the dogs fed on High fiber (/High protein) diet. Considering the current results, it is
possible that increased nesfatin-1 is another factor that may relate to satiety too.
Collectively, High fat/Low protein and High fiber/High protein diets increase
NUCB2/nesfatin-1 production in canine stomach, and it may relate to satiety effects in dogs.
It is reported that contraction of the stomach at the fasted state is controlled by
administrated nesfatin-1 in dogs [<xref rid="r31" ref-type="bibr">31</xref>], but there are
no reports indicating that administered nesfatin-1 influences food consumption in dogs like
rodent studies.</p><p>Limitations of the current study are as follows. First, we used the commercial diets which
were different in more than 2 kinds of dietary components. Ideally, we should use diets
which are different in only one nutrient, but when we change the amount of one nutrient of a
food, keeping the metabolizable energy constant, we have to change the amount of other
nutrients too, so it is difficult to design the desirable experimental protocol. Second,
there are no data which demonstrate the function of canine nesfatin-1, so the satiety
effects of nesfatin-1 remain unclear in dogs. It is difficult to evaluate the sense of
satiety in dogs, but there are some reports describing the satiety effects in dogs
objectively. Jewell and Toll [<xref rid="r13" ref-type="bibr">13</xref>] and Bosch
<italic>et al.</italic> [<xref rid="r2" ref-type="bibr">2</xref>] have evaluated the
effects of dietary fiber on satiety in dogs, in which, voluntary food intake of an
additional meal after consumption of the morning meal was found to be lower in the dogs fed
on high-fiber diets. Therefore, it will be a possible approach to investigate the
relationship between nesfatin-1 levels and satiety effects of dietary components in dogs
using the same methods for the next step. Third, influences of adipose nesfatin-1 are not
investigated. We analyzed NUCB2/nesfatin-1 in upper gastrointestinal tracts since they are
organs that contact dietary components, however, Stengel <italic>et al.</italic> [<xref rid="r28" ref-type="bibr">28</xref>] have reported that nesfatin-1 produced by adipose
tissues influences feeding and other metabolic actions. Although NUCB2/nesfatin-1 mRNA
expression in canine adipose tissue was poor in the current result, further studies are
necessary to prove the role of adipose nesfatin-1 in dogs.</p><p>In conclusion, the current study demonstrated that canine NUCB2/nasfatin-1 was very similar
to those of other species in molecular structure and tissue distribution. Plasma nesfatin-1
concentrations in the dogs were approximately 4 <italic>n</italic>g/m<italic>l</italic>, and
they did not change after feeding. On the other hand, High fiber/High protein and High
fat/Low protein diets increased gastric NUCB2/nesfatin-1 at transcriptional levels. These
results may set the stage for further investigations of canine NUCB2/nesfatin-1, which may
relate to satiety effects in dogs.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="pdf_001"><caption><title>Supplementary Table</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="jvms-78-411-s001.pdf" orientation="portrait" xlink:type="simple" id="d36e624" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="pdf_002"><caption><title>Supplementary figure</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="jvms-78-411-s002.pdf" orientation="portrait" xlink:type="simple" id="d36e629" position="anchor"/></supplementary-material></sec></body><back><ack><p>This research was supported in part by Scholarship Program 2010 from
Japanese Society of Veterinary Clinical Nutrition.</p></ack><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Bonnet</surname><given-names>M. S.</given-names></name><name><surname>Ouelaa</surname><given-names>W.</given-names></name><name><surname>Tillement</surname><given-names>V.</given-names></name><name><surname>Trouslard</surname><given-names>J.</given-names></name><name><surname>Jean</surname><given-names>A.</given-names></name><name><surname>Gonzalez</surname><given-names>B. J.</given-names></name><name><surname>Gourcerol</surname><given-names>G.</given-names></name><name><surname>Dallaporta</surname><given-names>M.</given-names></name><name><surname>Troadec</surname><given-names>J. D.</given-names></name><name><surname>Mounien</surname><given-names>L.</given-names></name></person-group><year>2013</year>. <article-title>Gastric distension activates
NUCB2/nesfatin-1-expressing neurons in the nucleus of the solitary
tract</article-title>. <source><italic>Regul. Pept.</italic></source><volume>187</volume>:
<fpage>17</fpage>&#x02013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.regpep.2013.10.001</pub-id><?supplied-pmid 24120633?><pub-id pub-id-type="pmid">24120633</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Bosch</surname><given-names>G.</given-names></name><name><surname>Verbrugghe</surname><given-names>A.</given-names></name><name><surname>Hesta</surname><given-names>M.</given-names></name><name><surname>Holst</surname><given-names>J. J.</given-names></name><name><surname>van der Poel</surname><given-names>A. F.</given-names></name><name><surname>Janssens</surname><given-names>G. P.</given-names></name><name><surname>Hendriks</surname><given-names>W. H.</given-names></name></person-group><year>2009</year>. <article-title>The effects of dietary fibre type on
satiety-related hormones and voluntary food intake in dogs</article-title>.
<source><italic>Br. J. Nutr.</italic></source><volume>102</volume>:
<fpage>318</fpage>&#x02013;<lpage>325</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S0007114508149194</pub-id><?supplied-pmid 19144213?><pub-id pub-id-type="pmid">19144213</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="book"><person-group><name><surname>Burkholder</surname><given-names>W. J.</given-names></name><name><surname>Toll</surname><given-names>P. W.</given-names></name></person-group><year>2000</year> Obesity. pp. 401&#x02013;403. <italic>In</italic>: Small Animal
Clinical Nutrition, 4th ed. (Michael, S. H., Craig, D. T., Rebecca, L. R., Philip, R. and
Lon, D. L. eds.), Mark Morris Institute, Topeka.</mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="book"><person-group><name><surname>Debraekeleer</surname><given-names>J.</given-names></name><name><surname>Gross</surname><given-names>K. L.</given-names></name><name><surname>Zicker</surname><given-names>S. C.</given-names></name></person-group><year>2000</year> Normal dogs. pp. 213&#x02013;260. <italic>In</italic>: Small
Animal Clinical Nutrition, 4th ed. (Michael, S. H., Craig, D. T., Rebecca, L. R., Philip,
R. and Lon, D. L. eds.), Mark Morris Institute, Topeka.</mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Delargy</surname><given-names>H. J.</given-names></name><name><surname>Burley</surname><given-names>V. J.</given-names></name><name><surname>O&#x02019;Sullivan</surname><given-names>K. R.</given-names></name><name><surname>Fletcher</surname><given-names>R. J.</given-names></name><name><surname>Blundell</surname><given-names>J. E.</given-names></name></person-group><year>1995</year>. <article-title>Effects of different soluble: insoluble
fibre ratios at breakfast on 24-h pattern of dietary intake and satiety</article-title>.
<source><italic>Eur. J. Clin. Nutr.</italic></source><volume>49</volume>:
<fpage>754</fpage>&#x02013;<lpage>766</lpage>. <?supplied-pmid 8536654?><pub-id pub-id-type="pmid">8536654</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Edney</surname><given-names>A. T.</given-names></name><name><surname>Smith</surname><given-names>P. M.</given-names></name></person-group><year>1986</year>. <article-title>Study of obesity in dogs visiting
veterinary practices in the United Kingdom</article-title>. <source><italic>Vet.
Rec.</italic></source><volume>118</volume>: <fpage>391</fpage>&#x02013;<lpage>396</lpage>.
doi: <pub-id pub-id-type="doi">10.1136/vr.118.14.391</pub-id><?supplied-pmid 3716092?><pub-id pub-id-type="pmid">3716092</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Foo</surname><given-names>K. S.</given-names></name><name><surname>Brismar</surname><given-names>H.</given-names></name><name><surname>Broberger</surname><given-names>C.</given-names></name></person-group><year>2008</year>. <article-title>Distribution and neuropeptide coexistence
of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS</article-title>.
<source><italic>Neuroscience</italic></source><volume>156</volume>:
<fpage>563</fpage>&#x02013;<lpage>579</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.07.054</pub-id><?supplied-pmid 18761059?><pub-id pub-id-type="pmid">18761059</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Foo</surname><given-names>K. S.</given-names></name><name><surname>Brauner</surname><given-names>H.</given-names></name><name><surname>Ostenson</surname><given-names>C. G.</given-names></name><name><surname>Broberger</surname><given-names>C.</given-names></name></person-group><year>2010</year>. <article-title>Nucleobindin-2/nesfatin in the endocrine
pancreas: distribution and relationship to glycaemic state</article-title>.
<source><italic>J. Endocrinol.</italic></source><volume>204</volume>:
<fpage>255</fpage>&#x02013;<lpage>263</lpage>. doi: <pub-id pub-id-type="doi">10.1677/JOE-09-0254</pub-id><?supplied-pmid 20032201?><pub-id pub-id-type="pmid">20032201</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Garc&#x000ed;a-Galiano</surname><given-names>D.</given-names></name><name><surname>Pineda</surname><given-names>R.</given-names></name><name><surname>Ilhan</surname><given-names>T.</given-names></name><name><surname>Castellano</surname><given-names>J. M.</given-names></name><name><surname>Ruiz-Pino</surname><given-names>F.</given-names></name><name><surname>S&#x000e1;nchez-Garrido</surname><given-names>M. A.</given-names></name><name><surname>Vazquez</surname><given-names>M. J.</given-names></name><name><surname>Sangiao-Alvarellos</surname><given-names>S.</given-names></name><name><surname>Romero-Ruiz</surname><given-names>A.</given-names></name><name><surname>Pinilla</surname><given-names>L.</given-names></name><name><surname>Di&#x000e9;guez</surname><given-names>C.</given-names></name><name><surname>Gayt&#x000e1;n</surname><given-names>F.</given-names></name><name><surname>Tena-Sempere</surname><given-names>M.</given-names></name></person-group><year>2012</year>. <article-title>Cellular distribution, regulated
expression, and functional role of the anorexigenic peptide, NUCB2/nesfatin-1, in the
testis</article-title>.
<source><italic>Endocrinology</italic></source><volume>153</volume>:
<fpage>1959</fpage>&#x02013;<lpage>1971</lpage>. doi: <pub-id pub-id-type="doi">10.1210/en.2011-2032</pub-id><?supplied-pmid 22334726?><pub-id pub-id-type="pmid">22334726</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>Gonkowski</surname><given-names>S.</given-names></name><name><surname>Rychlik</surname><given-names>A.</given-names></name><name><surname>Nowicki</surname><given-names>M.</given-names></name><name><surname>Nieradka</surname><given-names>R.</given-names></name><name><surname>Bulc</surname><given-names>M.</given-names></name><name><surname>Ca&#x00142;ka</surname><given-names>J.</given-names></name></person-group><year>2012</year>. <article-title>A population of nesfatin 1-like
immunoreactive (LI) cells in the mucosal layer of the canine digestive
tract</article-title>. <source><italic>Res. Vet.
Sci.</italic></source><volume>93</volume>: <fpage>1119</fpage>&#x02013;<lpage>1121</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/j.rvsc.2012.06.002</pub-id><?supplied-pmid 22749244?><pub-id pub-id-type="pmid">22749244</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Gonzalez</surname><given-names>R.</given-names></name><name><surname>Kerbel</surname><given-names>B.</given-names></name><name><surname>Chun</surname><given-names>A.</given-names></name><name><surname>Unniappan</surname><given-names>S.</given-names></name></person-group><year>2010</year>. <article-title>Molecular, cellular and physiological
evidences for the anorexigenic actions of nesfatin-1 in goldfish</article-title>.
<source><italic>PLoS ONE</italic></source><volume>5</volume>: <fpage>e15201</fpage>.
doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0015201</pub-id><?supplied-pmid 21151928?><pub-id pub-id-type="pmid">21151928</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Ishioka</surname><given-names>K.</given-names></name><name><surname>Soliman</surname><given-names>M. M.</given-names></name><name><surname>Sagawa</surname><given-names>M.</given-names></name><name><surname>Nakadomo</surname><given-names>F.</given-names></name><name><surname>Shibata</surname><given-names>H.</given-names></name><name><surname>Honjoh</surname><given-names>T.</given-names></name><name><surname>Hashimoto</surname><given-names>A.</given-names></name><name><surname>Kitamura</surname><given-names>H.</given-names></name><name><surname>Kimura</surname><given-names>K.</given-names></name><name><surname>Saito</surname><given-names>M.</given-names></name></person-group><year>2002</year>. <article-title>Experimental and clinical studies on
plasma leptin in obese dogs</article-title>. <source><italic>J. Vet. Med.
Sci.</italic></source><volume>64</volume>: <fpage>349</fpage>&#x02013;<lpage>353</lpage>. doi:
<pub-id pub-id-type="doi">10.1292/jvms.64.349</pub-id><?supplied-pmid 12014581?><pub-id pub-id-type="pmid">12014581</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Jewell</surname><given-names>D. E.</given-names></name><name><surname>Toll</surname><given-names>P. W.</given-names></name></person-group><year>1996</year>
<article-title>Effects of fiber on food intake in
dogs</article-title>. <source><italic>Vet. Clin.
Nutr.</italic></source><volume>3</volume>:
<fpage>115</fpage>&#x02013;<lpage>118</lpage>.</mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Kealy</surname><given-names>R. D.</given-names></name><name><surname>Lawler</surname><given-names>D. F.</given-names></name><name><surname>Ballam</surname><given-names>J. M.</given-names></name><name><surname>Mantz</surname><given-names>S. L.</given-names></name><name><surname>Biery</surname><given-names>D. N.</given-names></name><name><surname>Greeley</surname><given-names>E. H.</given-names></name><name><surname>Lust</surname><given-names>G.</given-names></name><name><surname>Segre</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>G. K.</given-names></name><name><surname>Stowe</surname><given-names>H. D.</given-names></name></person-group><year>2002</year>. <article-title>Effects of diet restriction on life span
and age-related changes in dogs</article-title>. <source><italic>J. Am. Vet. Med.
Assoc.</italic></source><volume>220</volume>: <fpage>1315</fpage>&#x02013;<lpage>1320</lpage>.
doi: <pub-id pub-id-type="doi">10.2460/javma.2002.220.1315</pub-id><?supplied-pmid 11991408?><pub-id pub-id-type="pmid">11991408</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Kohno</surname><given-names>D.</given-names></name><name><surname>Nakata</surname><given-names>M.</given-names></name><name><surname>Maejima</surname><given-names>Y.</given-names></name><name><surname>Shimizu</surname><given-names>H.</given-names></name><name><surname>Sedbazar</surname><given-names>U.</given-names></name><name><surname>Yoshida</surname><given-names>N.</given-names></name><name><surname>Dezaki</surname><given-names>K.</given-names></name><name><surname>Onaka</surname><given-names>T.</given-names></name><name><surname>Mori</surname><given-names>M.</given-names></name><name><surname>Yada</surname><given-names>T.</given-names></name></person-group><year>2008</year>. <article-title>Nesfatin-1 neurons in paraventricular and
supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are
activated by refeeding</article-title>.
<source><italic>Endocrinology</italic></source><volume>149</volume>:
<fpage>1295</fpage>&#x02013;<lpage>1301</lpage>. doi: <pub-id pub-id-type="doi">10.1210/en.2007-1276</pub-id><?supplied-pmid 18048495?><pub-id pub-id-type="pmid">18048495</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Krotkiewski</surname><given-names>M.</given-names></name></person-group><year>1984</year>. <article-title>Effect of guar gum on body-weight, hunger
ratings and metabolism in obese subjects</article-title>. <source><italic>Br. J.
Nutr.</italic></source><volume>52</volume>: <fpage>97</fpage>&#x02013;<lpage>105</lpage>. doi:
<pub-id pub-id-type="doi">10.1079/BJN19840075</pub-id><?supplied-pmid 6331498?><pub-id pub-id-type="pmid">6331498</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Maejima</surname><given-names>Y.</given-names></name><name><surname>Sedbazar</surname><given-names>U.</given-names></name><name><surname>Iwasaki</surname><given-names>Y.</given-names></name><name><surname>Takano</surname><given-names>E.</given-names></name><name><surname>Yada</surname><given-names>T.</given-names></name></person-group><year>2011</year>. <article-title>The nesfatin-1 anorectic neural pathway
and its role in stress, circulation, and reproduction</article-title>.
<source><italic>Nippon Yakurigaku Zasshi</italic></source><volume>137</volume>:
<fpage>162</fpage>&#x02013;<lpage>165</lpage>. doi: <pub-id pub-id-type="doi">10.1254/fpj.137.162</pub-id><?supplied-pmid 21478634?><pub-id pub-id-type="pmid">21478634</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Maejima</surname><given-names>Y.</given-names></name><name><surname>Sedbazar</surname><given-names>U.</given-names></name><name><surname>Suyama</surname><given-names>S.</given-names></name><name><surname>Kohno</surname><given-names>D.</given-names></name><name><surname>Onaka</surname><given-names>T.</given-names></name><name><surname>Takano</surname><given-names>E.</given-names></name><name><surname>Yoshida</surname><given-names>N.</given-names></name><name><surname>Koike</surname><given-names>M.</given-names></name><name><surname>Uchiyama</surname><given-names>Y.</given-names></name><name><surname>Fujiwara</surname><given-names>K.</given-names></name><name><surname>Yashiro</surname><given-names>T.</given-names></name><name><surname>Horvath</surname><given-names>T. L.</given-names></name><name><surname>Dietrich</surname><given-names>M. O.</given-names></name><name><surname>Tanaka</surname><given-names>S.</given-names></name><name><surname>Dezaki</surname><given-names>K.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name><name><surname>Shimizu</surname><given-names>H.</given-names></name><name><surname>Nakata</surname><given-names>M.</given-names></name><name><surname>Mori</surname><given-names>M.</given-names></name><name><surname>Yada</surname><given-names>T.</given-names></name></person-group><year>2009</year>. <article-title>Nesfatin-1-regulated oxytocinergic
signaling in the paraventricular nucleus causes anorexia through a leptin-independent
melanocortin pathway</article-title>. <source><italic>Cell
Metab.</italic></source><volume>10</volume>: <fpage>355</fpage>&#x02013;<lpage>365</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/j.cmet.2009.09.002</pub-id><?supplied-pmid 19883614?><pub-id pub-id-type="pmid">19883614</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group><name><surname>Oh-I</surname><given-names>S.</given-names></name><name><surname>Shimizu</surname><given-names>H.</given-names></name><name><surname>Satoh</surname><given-names>T.</given-names></name><name><surname>Okada</surname><given-names>S.</given-names></name><name><surname>Adachi</surname><given-names>S.</given-names></name><name><surname>Inoue</surname><given-names>K.</given-names></name><name><surname>Eguchi</surname><given-names>H.</given-names></name><name><surname>Yamamoto</surname><given-names>M.</given-names></name><name><surname>Imaki</surname><given-names>T.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name><name><surname>Tsuchiya</surname><given-names>T.</given-names></name><name><surname>Monden</surname><given-names>T.</given-names></name><name><surname>Horiguchi</surname><given-names>K.</given-names></name><name><surname>Yamada</surname><given-names>M.</given-names></name><name><surname>Mori</surname><given-names>M.</given-names></name></person-group><year>2006</year>. <article-title>Identification of nesfatin-1 as a satiety
molecule in the hypothalamus</article-title>.
<source><italic>Nature</italic></source><volume>443</volume>:
<fpage>709</fpage>&#x02013;<lpage>712</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature05162</pub-id><?supplied-pmid 17036007?><pub-id pub-id-type="pmid">17036007</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group><name><surname>Pan</surname><given-names>W.</given-names></name><name><surname>Hsuchou</surname><given-names>H.</given-names></name><name><surname>Kastin</surname><given-names>A. J.</given-names></name></person-group><year>2007</year>. <article-title>Nesfatin-1 crosses the blood-brain
barrier without saturation</article-title>.
<source><italic>Peptides</italic></source><volume>28</volume>:
<fpage>2223</fpage>&#x02013;<lpage>2228</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.peptides.2007.09.005</pub-id><?supplied-pmid 17950952?><pub-id pub-id-type="pmid">17950952</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group><name><surname>Pappas</surname><given-names>T. N.</given-names></name><name><surname>Melendez</surname><given-names>R. L.</given-names></name><name><surname>Debas</surname><given-names>H. T.</given-names></name></person-group><year>1989</year>. <article-title>Gastric distension is a physiologic
satiety signal in the dog</article-title>. <source><italic>Dig. Dis.
Sci.</italic></source><volume>34</volume>: <fpage>1489</fpage>&#x02013;<lpage>1493</lpage>. doi:
<pub-id pub-id-type="doi">10.1007/BF01537098</pub-id><?supplied-pmid 2791798?><pub-id pub-id-type="pmid">2791798</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group><name><surname>Pasman</surname><given-names>W. J.</given-names></name><name><surname>Saris</surname><given-names>W. H.</given-names></name><name><surname>Wauters</surname><given-names>M. A.</given-names></name><name><surname>Westerterp-Plantenga</surname><given-names>M. S.</given-names></name></person-group><year>1997</year>. <article-title>Effect of one week of fibre
supplementation on hunger and satiety ratings and energy intake</article-title>.
<source><italic>Appetite</italic></source><volume>29</volume>:
<fpage>77</fpage>&#x02013;<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.1006/appe.1997.0091</pub-id><?supplied-pmid 9268427?><pub-id pub-id-type="pmid">9268427</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group><name><surname>Price</surname><given-names>T. O.</given-names></name><name><surname>Samson</surname><given-names>W. K.</given-names></name><name><surname>Niehoff</surname><given-names>M. L.</given-names></name><name><surname>Banks</surname><given-names>W. A.</given-names></name></person-group><year>2007</year>. <article-title>Permeability of the blood-brain barrier
to a novel satiety molecule nesfatin-1</article-title>.
<source><italic>Peptides</italic></source><volume>28</volume>:
<fpage>2372</fpage>&#x02013;<lpage>2381</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.peptides.2007.10.008</pub-id><?supplied-pmid 18006117?><pub-id pub-id-type="pmid">18006117</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group><name><surname>Ramanjaneya</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Brown</surname><given-names>J. E.</given-names></name><name><surname>Tripathi</surname><given-names>G.</given-names></name><name><surname>Hallschmid</surname><given-names>M.</given-names></name><name><surname>Patel</surname><given-names>S.</given-names></name><name><surname>Kern</surname><given-names>W.</given-names></name><name><surname>Hillhouse</surname><given-names>E. W.</given-names></name><name><surname>Lehnert</surname><given-names>H.</given-names></name><name><surname>Tan</surname><given-names>B. K.</given-names></name><name><surname>Randeva</surname><given-names>H. S.</given-names></name></person-group><year>2010</year>. <article-title>Identification of nesfatin-1 in human and
murine adipose tissue: a novel depot-specific adipokine with increased levels in
obesity</article-title>.
<source><italic>Endocrinology</italic></source><volume>151</volume>:
<fpage>3169</fpage>&#x02013;<lpage>3180</lpage>. doi: <pub-id pub-id-type="doi">10.1210/en.2009-1358</pub-id><?supplied-pmid 20427481?><pub-id pub-id-type="pmid">20427481</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group><name><surname>Shimizu</surname><given-names>H.</given-names></name><name><surname>Ohsaki</surname><given-names>A.</given-names></name><name><surname>Oh-I</surname><given-names>S.</given-names></name><name><surname>Okada</surname><given-names>S.</given-names></name><name><surname>Mori</surname><given-names>M.</given-names></name></person-group><year>2009</year>. <article-title>A new anorexigenic protein,
nesfatin-1</article-title>.
<source><italic>Peptides</italic></source><volume>30</volume>:
<fpage>995</fpage>&#x02013;<lpage>998</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.peptides.2009.01.002</pub-id><?supplied-pmid 19452636?><pub-id pub-id-type="pmid">19452636</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group><name><surname>Shimizu</surname><given-names>H.</given-names></name><name><surname>Oh-I</surname><given-names>S.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name><name><surname>Nakata</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>S.</given-names></name><name><surname>Yoshida</surname><given-names>N.</given-names></name><name><surname>Eguchi</surname><given-names>H.</given-names></name><name><surname>Kato</surname><given-names>I.</given-names></name><name><surname>Inoue</surname><given-names>K.</given-names></name><name><surname>Satoh</surname><given-names>T.</given-names></name><name><surname>Okada</surname><given-names>S.</given-names></name><name><surname>Yamada</surname><given-names>M.</given-names></name><name><surname>Yada</surname><given-names>T.</given-names></name><name><surname>Mori</surname><given-names>M.</given-names></name></person-group><year>2009</year>. <article-title>Peripheral administration of nesfatin-1
reduces food intake in mice: the leptin-independent mechanism</article-title>.
<source><italic>Endocrinology</italic></source><volume>150</volume>:
<fpage>662</fpage>&#x02013;<lpage>671</lpage>. doi: <pub-id pub-id-type="doi">10.1210/en.2008-0598</pub-id><?supplied-pmid 19176321?><pub-id pub-id-type="pmid">19176321</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group><name><surname>Stengel</surname><given-names>A.</given-names></name><name><surname>Goebel</surname><given-names>M.</given-names></name><name><surname>Yakubov</surname><given-names>I.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Witcher</surname><given-names>D.</given-names></name><name><surname>Coskun</surname><given-names>T.</given-names></name><name><surname>Tache</surname><given-names>Y.</given-names></name><name><surname>Sachs</surname><given-names>G.</given-names></name><name><surname>Lambrecht</surname><given-names>N. W.</given-names></name></person-group><year>2009</year>. <article-title>Identification and characterization of
nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic
mucosa</article-title>.
<source><italic>Endocrinology</italic></source><volume>150</volume>:
<fpage>232</fpage>&#x02013;<lpage>238</lpage>. doi: <pub-id pub-id-type="doi">10.1210/en.2008-0747</pub-id><?supplied-pmid 18818289?><pub-id pub-id-type="pmid">18818289</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group><name><surname>Stengel</surname><given-names>A.</given-names></name><name><surname>Mori</surname><given-names>M.</given-names></name><name><surname>Tach&#x000e9;</surname><given-names>Y.</given-names></name></person-group><year>2013</year>. <article-title>The role of nesfatin-1 in the regulation
of food intake and body weight: recent developments and future
endeavors</article-title>. <source><italic>Obes.
Rev.</italic></source><volume>14</volume>: <fpage>859</fpage>&#x02013;<lpage>870</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/obr.12063</pub-id><?supplied-pmid 23980879?><pub-id pub-id-type="pmid">23980879</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group><name><surname>Tian</surname><given-names>Z. B.</given-names></name><name><surname>Deng</surname><given-names>R. J.</given-names></name><name><surname>Sun</surname><given-names>G. R.</given-names></name><name><surname>Wei</surname><given-names>L. Z.</given-names></name><name><surname>Kong</surname><given-names>X. J.</given-names></name><name><surname>Ding</surname><given-names>X. L.</given-names></name><name><surname>Jing</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>C. P.</given-names></name><name><surname>Ge</surname><given-names>Y. L.</given-names></name></person-group><year>2014</year>. <article-title>Expression of gastrointestinal nesfatin-1
and gastric emptying in ventromedial hypothalamic nucleus- and ventrolateral
hypothalamic nucleus-lesioned rats</article-title>. <source><italic>World J.
Gastroenterol.</italic></source><volume>20</volume>:
<fpage>6897</fpage>&#x02013;<lpage>6905</lpage>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v20.i22.6897</pub-id><?supplied-pmid 24944480?><pub-id pub-id-type="pmid">24944480</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group><name><surname>Tsuchiya</surname><given-names>T.</given-names></name><name><surname>Shimizu</surname><given-names>H.</given-names></name><name><surname>Yamada</surname><given-names>M.</given-names></name><name><surname>Osaki</surname><given-names>A.</given-names></name><name><surname>Oh-I</surname><given-names>S.</given-names></name><name><surname>Ariyama</surname><given-names>Y.</given-names></name><name><surname>Takahashi</surname><given-names>H.</given-names></name><name><surname>Okada</surname><given-names>S.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name><name><surname>Satoh</surname><given-names>T.</given-names></name><name><surname>Kojima</surname><given-names>M.</given-names></name><name><surname>Mori</surname><given-names>M.</given-names></name></person-group><year>2010</year>. <article-title>Fasting concentrations of nesfatin-1 are
negatively correlated with body mass index in non-obese males</article-title>.
<source><italic>Clin. Endocrinol. (Oxf.)</italic></source><volume>73</volume>:
<fpage>484</fpage>&#x02013;<lpage>490</lpage>. <?supplied-pmid 20550530?><pub-id pub-id-type="pmid">20550530</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group><name><surname>Watanabe</surname><given-names>A.</given-names></name><name><surname>Mochiki</surname><given-names>E.</given-names></name><name><surname>Kimura</surname><given-names>A.</given-names></name><name><surname>Kogure</surname><given-names>N.</given-names></name><name><surname>Yanai</surname><given-names>M.</given-names></name><name><surname>Ogawa</surname><given-names>A.</given-names></name><name><surname>Toyomasu</surname><given-names>Y.</given-names></name><name><surname>Ogata</surname><given-names>K.</given-names></name><name><surname>Ohno</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>H.</given-names></name><name><surname>Kuwano</surname><given-names>H.</given-names></name></person-group><year>2015</year>. <article-title>Nesfatin-1 suppresses gastric
contractions and inhibits interdigestive migrating contractions in conscious
dogs</article-title>. <source><italic>Dig. Dis.
Sci.</italic></source><volume>60</volume>: <fpage>1595</fpage>&#x02013;<lpage>1602</lpage>. doi:
<pub-id pub-id-type="doi">10.1007/s10620-014-3505-8</pub-id><?supplied-pmid 25563722?><pub-id pub-id-type="pmid">25563722</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group><name><surname>Whelan</surname><given-names>J. A.</given-names></name><name><surname>Russell</surname><given-names>N. B.</given-names></name><name><surname>Whelan</surname><given-names>M. A.</given-names></name></person-group><year>2003</year>. <article-title>A method for the absolute quantification
of cDNA using real-time PCR</article-title>. <source><italic>J. Immunol.
Methods</italic></source><volume>278</volume>: <fpage>261</fpage>&#x02013;<lpage>269</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/S0022-1759(03)00223-0</pub-id><?supplied-pmid 12957413?><pub-id pub-id-type="pmid">12957413</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group><name><surname>Wilmshurst</surname><given-names>P.</given-names></name><name><surname>Crawley</surname><given-names>J. C.</given-names></name></person-group><year>1980</year>. <article-title>The measurement of gastric transit time
in obese subjects using 24Na and the effects of energy content and guar gum on gastric
emptying and satiety</article-title>. <source><italic>Br. J.
Nutr.</italic></source><volume>44</volume>: <fpage>1</fpage>&#x02013;<lpage>6</lpage>. doi:
<pub-id pub-id-type="doi">10.1079/BJN19800003</pub-id><?supplied-pmid 7426600?><pub-id pub-id-type="pmid">7426600</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group><name><surname>Wynne</surname><given-names>K.</given-names></name><name><surname>Stanley</surname><given-names>S.</given-names></name><name><surname>McGowan</surname><given-names>B.</given-names></name><name><surname>Bloom</surname><given-names>S. R.</given-names></name></person-group><year>2005</year>. <article-title>Appetite control</article-title>.
<source><italic>J. Endocrinol.</italic></source><volume>184</volume>:
<fpage>291</fpage>&#x02013;<lpage>318</lpage>. doi: <pub-id pub-id-type="doi">10.1677/joe.1.05866</pub-id><?supplied-pmid 15684339?><pub-id pub-id-type="pmid">15684339</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group><name><surname>Zhang</surname><given-names>A. Q.</given-names></name><name><surname>Li</surname><given-names>X. L.</given-names></name><name><surname>Jiang</surname><given-names>C. Y.</given-names></name><name><surname>Lin</surname><given-names>L.</given-names></name><name><surname>Shi</surname><given-names>R. H.</given-names></name><name><surname>Chen</surname><given-names>J. D.</given-names></name><name><surname>Oomura</surname><given-names>Y.</given-names></name></person-group><year>2010</year>. <article-title>Expression of nesfatin-1/NUCB2 in rodent
digestive system</article-title>. <source><italic>World J.
Gastroenterol.</italic></source><volume>16</volume>:
<fpage>1735</fpage>&#x02013;<lpage>1741</lpage>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v16.i14.1735</pub-id><?supplied-pmid 20380005?><pub-id pub-id-type="pmid">20380005</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Fritze</surname><given-names>D.</given-names></name><name><surname>Chai</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Mulholland</surname><given-names>M. W.</given-names></name></person-group><year>2013</year>. <article-title>Modulation of food intake by mTOR
signalling in the dorsal motor nucleus of the vagus in male rats: Focus on ghrelin and
nesfatin-1</article-title>. <source><italic>Exp.
Physiol.</italic></source><volume>98</volume>: <fpage>1696</fpage>&#x02013;<lpage>1704</lpage>.
doi: <pub-id pub-id-type="doi">10.1113/expphysiol.2013.074930</pub-id><?supplied-pmid 23955309?><pub-id pub-id-type="pmid">23955309</pub-id></mixed-citation></ref></ref-list></back></article>